Pharma News, 2020

Nautilus Biotechnology, a company pioneering a high-throughput, low-cost platform for analyzing and quantifying the human proteome, today announced it has raised $76m in an oversubscribed Series B off...

Bypassing clinical trials for a potential SARS-CoV-2 vaccine would be "catastrophic," says Science Advances deputy editor Douglas Green in this Editorial.

Genentech has shared longer-term phase 3 safety data on its anti-IL-6 antibody satralizumab, adding to the evidence in support of the drug ahead of a FDA decision to approve it in a rare disease serve...

After Amarin suffered a surprise patent loss for its key drug Vascepa, the company is appealing and generics makers are hoping their arguments hold.

GlaxoSmithKline and Samsung Biologics have teamed up to give GSK additional capacity to manufacture and supply its biopharmaceutical therapies.

Antibody tests will be available to NHS and care staff, eligible patients and care residents in England to see if they have had coronavirus as part of a new national antibody testing programme announc...

CanSino Biologics is already testing a recombinant conronavirus vaccine in China, but it’s jumping on the mRNA vaccine bandwagon through a licensing deal with Precision NanoSystems.

Beximco Pharmaceuticals Limited (“Beximco Pharma”, “BPL” or “the Company”), the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, ...

In an innovative study, Radboudumc and LUMC jointly tested a candidate vaccine based on a genetically weakened malaria parasite.

SYDNEY, May 18 (Xinhua) -- Online self-diagnosis tools only get it right about once every three diagnoses given, a new study revealed on Monday, raising serious concerns for those making healt...

Roche has signed up for access to Vividion Therapeutics' proteomics screening platform and proprietary small molecule library to target E3 ligases and a range of oncology and immunology therapeuti...

NHS England is calling on people with diabetes to access the help available to them after new research showed that those living with the condition are at significantly higher risk of dying with COVID-...